BIIB059, A MONOCLONAL ANTIBODY TARGETING BDCA2, SHOWS EVIDENCE OF BIOLOGICAL ACTIVITY AND EARLY CLINICAL PROOF OF CONCEPT IN SUBJECTS WITH ACTIVE CUTANEOUS LE-MedSci.cn

BIIB059, A MONOCLONAL ANTIBODY TARGETING BDCA2, SHOWS EVIDENCE OF BIOLOGICAL ACTIVITY AND EARLY CLINICAL PROOF OF CONCEPT IN SUBJECTS WITH ACTIVE CUTANEOUS LE

Furie, R; Werth, VP; Merola, JF; Reynolds, TL; Stevenson, L; Wang, W; Smirnakis, K; Barbey, C; Musselli, C; Werneburg, B; Rabah, D; Franchimont, N

ANNALS OF THE RHEUMATIC DISEASES, 2017; 76 ( ): 857

科室
- - 订阅+
  - 更多科室
工具
服务